IOBT
Price
$0.48
Change
+$0.04 (+9.09%)
Updated
Oct 3 closing price
Capitalization
28.66M
32 days until earnings call
Intraday Buy/Sell Signals
MLTX
Price
$8.43
Change
+$0.97 (+13.00%)
Updated
Oct 3 closing price
Capitalization
473.72M
45 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

IOBT vs MLTX

Header iconIOBT vs MLTX Comparison
Open Charts IOBT vs MLTXBanner chart's image
IO Biotech
Price$0.48
Change+$0.04 (+9.09%)
Volume$5.57M
Capitalization28.66M
MoonLake Immunotherapeutics
Price$8.43
Change+$0.97 (+13.00%)
Volume$15.62M
Capitalization473.72M
IOBT vs MLTX Comparison Chart in %
Loading...
IOBT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IOBT vs. MLTX commentary
Oct 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IOBT is a Hold and MLTX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 05, 2025
Stock price -- (IOBT: $0.48 vs. MLTX: $8.43)
Brand notoriety: IOBT and MLTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IOBT: 99% vs. MLTX: 400%
Market capitalization -- IOBT: $28.66M vs. MLTX: $473.72M
IOBT [@Biotechnology] is valued at $28.66M. MLTX’s [@Biotechnology] market capitalization is $473.72M. The market cap for tickers in the [@Biotechnology] industry ranges from $104.83B to $0. The average market capitalization across the [@Biotechnology] industry is $2.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IOBT’s FA Score shows that 0 FA rating(s) are green whileMLTX’s FA Score has 1 green FA rating(s).

  • IOBT’s FA Score: 0 green, 5 red.
  • MLTX’s FA Score: 1 green, 4 red.
According to our system of comparison, MLTX is a better buy in the long-term than IOBT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IOBT’s TA Score shows that 4 TA indicator(s) are bullish while MLTX’s TA Score has 5 bullish TA indicator(s).

  • IOBT’s TA Score: 4 bullish, 5 bearish.
  • MLTX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, MLTX is a better buy in the short-term than IOBT.

Price Growth

IOBT (@Biotechnology) experienced а -69.49% price change this week, while MLTX (@Biotechnology) price change was -86.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.93%. For the same industry, the average monthly price growth was +13.11%, and the average quarterly price growth was +84.39%.

Reported Earning Dates

IOBT is expected to report earnings on Nov 05, 2025.

MLTX is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+4.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLTX($474M) has a higher market cap than IOBT($28.7M). IOBT YTD gains are higher at: -47.609 vs. MLTX (-84.432). IOBT has higher annual earnings (EBITDA): -103.06M vs. MLTX (-196.98M). MLTX has more cash in the bank: 425M vs. IOBT (28.1M). IOBT has less debt than MLTX: IOBT (8.36M) vs MLTX (75.8M). IOBT (0) and MLTX (0) have equivalent revenues.
IOBTMLTXIOBT / MLTX
Capitalization28.7M474M6%
EBITDA-103.06M-196.98M52%
Gain YTD-47.609-84.43256%
P/E RatioN/AN/A-
Revenue00-
Total Cash28.1M425M7%
Total Debt8.36M75.8M11%
TECHNICAL ANALYSIS
Technical Analysis
IOBTMLTX
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
69%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
67%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
60%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
59%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
58%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
58%
Advances
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 18 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
IOBT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LVWR5.310.23
+4.53%
LiveWire Group
ONTF5.700.11
+1.97%
ON24
FTDR68.720.40
+0.59%
Frontdoor
INFY16.230.08
+0.50%
Infosys Limited
NTCL1.39N/A
N/A
Netclass Technology Inc

IOBT and

Correlation & Price change

A.I.dvisor indicates that over the last year, IOBT has been closely correlated with MLTX. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if IOBT jumps, then MLTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IOBT
1D Price
Change %
IOBT100%
+10.80%
MLTX - IOBT
78%
Closely correlated
+13.00%
KALA - IOBT
73%
Closely correlated
N/A
AUPH - IOBT
31%
Poorly correlated
+0.80%
KURA - IOBT
30%
Poorly correlated
+4.70%
NEVPF - IOBT
30%
Poorly correlated
N/A
More

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been closely correlated with KALA. These tickers have moved in lockstep 89% of the time. This A.I.-generated data suggests there is a high statistical probability that if MLTX jumps, then KALA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
+13.00%
KALA - MLTX
89%
Closely correlated
N/A
IOBT - MLTX
78%
Closely correlated
+10.80%
XNCR - MLTX
50%
Loosely correlated
-0.42%
NUVL - MLTX
49%
Loosely correlated
+0.43%
NRIX - MLTX
45%
Loosely correlated
+3.30%
More